Study will advance the validation of Cellvizio® as a real-time biopsy guidance tool during robotic-assisted bronchoscopy Regulatory News: Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®
Cash position of €6.7m at May 31, 2023 strengthened by USD 2.5m received from the joint venture with Tasly Pharmaceutical Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (OTCQX:MKEAY)
Making better measurements of the composition of galaxies sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.